Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Southampton researchers to study new treatment for knee arthritis
Doctors in Southampton are set to trial a new treatment for people suffering from knee arthritis.
Avita Medical's ReCell demonstrates 78% skin repigmentation, compared to 0% control
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that statistically significant data from a randomized controlled study...
Diabetes drug proves effective weight-loss aid
Compared with placebo, a diabetes drug recently given approval for weight loss - liraglutide (Saxenda) - produced an average loss of 5.6 kg at a daily dose of 3.0 mg.
Second-line cetuximab active beyond progression in quadruple wild-type patients with metastatic colorectal cancer
Patients with metastatic colorectal cancer (mCRC) that are mutation-free in the KRAS, NRAS, BRAF and PIK3CA genes showed significant benefit from continuing anti-epidermal growth factor receptor...
Bosutinib is well-suited for older patients with chronic myeloid leukemia
In our final report from the 20th Congress of the European Hematology Association, we look at the results of a clinical trial for the tyrosine kinase inhibitor bosutinib.
Erythropoietic protoporphyria: Phase III SCENESSE studies published
Clinuvel Pharmaceuticals Ltd has announced that results from its pivotal Phase III studies of SCENESSE® (afamelanotide 16mg) in the orphan genetic disorder erythropoietic protoporphyria (EPP)...
Cystic fibrosis gene therapy trial offers hope of treatment
A trial to test the safety and effectiveness of a therapy that replaces a faulty gene in the lungs of patients with cystic fibrosis has shown encouraging results.
Clinical trial: Melatonin offers hope for ADHD bedtime shut-eye
Sleep is vital to wellbeing, but children with attention deficit hyperactivity disorder (ADHD) often have trouble drifting off.
Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer
The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC), researchers announced at the ESMO 17th World Congress...
Clinical investigation reviews approaches and outcomes of Africa-based HIV trials
A new article in Clinical Investigation highlights the learnings gleaned from monitoring several complex HIV clinical trials in Africa over a 15 year period.
Positive top-line results from stroke and TBI cohorts of PRISM II study announced
Avanir Pharmaceuticals, Inc. has announced top-line data from the PRISM II study showing that treatment with NUEDEXTA® was associated with a statistically significant reduction in symptoms of...
Pitt leads trial to reduce antibiotic overuse at post-acute and long-term care facilities
The University of Pittsburgh School of Medicine will be leading a $1.5 million national trial to examine methods to reduce unnecessary use of antibiotics in post-acute and long-term care...
Ruxolitinib is useful for long-term treatment of polycythemia vera
From the 20th Congress of the European Hematology Association, we report on evidence for ruxolitinib as a long-term polycythemia vera treatment.
Researchers seek to answer "obesity paradox"
A world-first study at Oxford's John Radcliffe Hospital is seeking to answer the "obesity paradox" of the link between being overweight and heart function.
Moffitt Cancer Center receives $3.6 million grant to study e-cigarettes
Moffitt Cancer Center received a $3.6 million grant from the National Institutes of Health to study the use of electronic cigarettes, or e-cigarettes, over the next five years.
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2015
Content Management / Website Design by Tresware